Skip to main content
. 2019 Jul 6;10(1):271–281. doi: 10.1080/21655979.2019.1632668

Figure 1.

Figure 1.

Expression of miR-25 is associated with lymph node metastasis and survival of NSCLC patients. (a) relative expression of miR-25 was compared between lymph node metastasis (N1) and without lymph node metastasis (N0), and between patients in stage I-II and patients in stage III. Mann–Whitney U test was used. Box and whisker show median value with 10–90% percentile. (b) 67 NSCLC patients with their following information available were classified into high expression group (n= 21) and low expression group (n= 46) by the 75th percentiles of 2ΔΔCt. Shown is Kaplan-Meier overall survival curves of two group patients, Log-rank test was used.